Nicotine Skin Patch in Treating Patients With Kaposi's Sarcoma
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Nicotine may stimulate the immune system to kill Kaposi's sarcoma cells.
PURPOSE: This phase II trial is studying the side effects and how well the nicotine skin
patch works in treating patients with Kaposi's sarcoma.